These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6189726)

  • 41. Antibodies to immunoglobulin heavy chain variable regions protect helper cells from specific suicide by radiolabeled antigen.
    Puri J; Ben-Neriah Y; Givol D; Lonai P
    Eur J Immunol; 1980 Apr; 10(4):281-4. PubMed ID: 6156844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of allelic V kappa-1 region genes in inbred strains of mice.
    Ng KH; Lavigueur A; Ricard L; Boivrette M; Maclean S; Cloutier D; Gibson DM
    J Immunol; 1989 Jul; 143(2):638-48. PubMed ID: 2567773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
    Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
    Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An unusual mouse myeloma protein binding native DNA.
    Dixon JA; Sugai S; Talal N
    Clin Exp Immunol; 1975 Feb; 19(2):347-54. PubMed ID: 813922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An idiotypic marker for the VL region of an homogeneous antibody.
    Sogn JA; Yarmush ML; Kindt TJ
    Ann Immunol (Paris); 1976; 127(3-4):397-408. PubMed ID: 822775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isotype modulation of idiotypic expression in recombinant isotypic variants of MOPC 315.
    Rinfret A; Horne C; Boux H; Marks A; Dorrington KJ; Klein M
    J Immunol; 1990 Aug; 145(3):925-31. PubMed ID: 2373863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Individual antigenic specificity of mouse myeloma proteins].
    Kolb JP; Lespinats G
    Eur J Immunol; 1973 Nov; 3(11):707-10. PubMed ID: 4129487
    [No Abstract]   [Full Text] [Related]  

  • 48. Preparation and characterization of antibodies to the lambda chain variable region (Vlambda) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Gavish M; Givol D
    Eur J Immunol; 1978 Nov; 8(11):792-6. PubMed ID: 82511
    [No Abstract]   [Full Text] [Related]  

  • 49. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins.
    Sirisinha S; Eisen HN
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3130-5. PubMed ID: 4108872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand-induced redistribution and augmentation of surface-bound myeloma protein on MOPC 315 plasmacytoma cells.
    Hannestad K; Gaudernack G
    Scand J Immunol; 1977; 6(1-2):59-76. PubMed ID: 403594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.
    Chen Y; Yakulis V; Heller P
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):121-5. PubMed ID: 1250837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of isotype exclusion and expression of aberrant lambda light chain on secreted MOPC-315 myeloma proteins.
    Ju ST; Pinto D; Dorf ME
    Mol Immunol; 1986 Jan; 23(1):79-85. PubMed ID: 3083241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system.
    Hannestad K; Kao MS; Eisen HN
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2295-9. PubMed ID: 4626403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myeloma proteins as tumor-specific transplantation antigens.
    Lynch RG; Graff RJ; Sirisinha S; Simms ES; Eisen HN
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1540-4. PubMed ID: 4113870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of growth of allogeneic mouse tumor by the IgG1 fraction of alloantibody preparations.
    Harris TN; Harris S; Henri EM; Farber MB
    J Natl Cancer Inst; 1978 Jan; 60(1):167-72. PubMed ID: 628014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subunit structure and number of combining sites of the immunoglobulin A myeloma protein produced by mouse plasmacytoma MOPC-315.
    Underdown BJ; Simms ES; Eisen HN
    Biochemistry; 1971 Nov; 10(24):4359-68. PubMed ID: 5142616
    [No Abstract]   [Full Text] [Related]  

  • 57. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline.
    Potter M; Lieberman R
    J Exp Med; 1970 Oct; 132(4):737-51. PubMed ID: 4101363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the growth characteristics of a primary BALB/c IgG plasmacytoma.
    Hentschel R; Kölsch E
    Int J Cancer; 1983 Jun; 31(6):749-56. PubMed ID: 6862684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular J chain in mouse plasmacytomas secreting IgA, IgM and IgG.
    Kaji H; Parkhouse RM
    Nature; 1974 May; 249(452):45-7. PubMed ID: 4208428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.